54gene
Latest round
- Series B
Last raised
- Sep 2021
Total raised
- $45M
Investors
- 15
About 54gene
54gene Inc.Founded in 2019 and headquartered in San Francisco, US, 54gene Inc. operates in the genomic research sector, providing extensive diagnostic solutions.54gene focuses on genomic research and diagnostic solutions, aiming to enhance healthcare outcomes through innovative genetic testing. Their primary offerings include advanced genomic sequencing services, utilized for applications such as disease diagnosis, drug discovery, and personalized medicine. The company serves healthcare institutions, pharmaceutical companies, and research organizations, providing them with essential tools for advancing genetic research and therapeutic development.54gene's revenue model is based on contracts with healthcare providers, research institutions, and pharmaceutical companies for genomic sequencing services. Transactions occur through agreements for specific studies or testing projects, which may involve one-time fees or ongoing partnerships based on a subscription model for access to genomic databases and analytical tools.00 mn in September 2021, 54gene plans to utilize the capital to expand its presence across the African continent. The company is focused on launching new products designed to enhance its genomic service offerings, with specific release dates to be determined as development progresses. Through these initiatives, 54gene aims to tap into new markets and strengthen its position in the evolving landscape of genomic research.
Who invested in 54gene
15 investors across 3 rounds
See all investors in 54gene
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about 54gene
Who invested in 54gene?
54gene has 15 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has 54gene raised?
54gene has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did 54gene last raise money?
54gene's most recent round on record is a Series B, in Sep 2021.
What does 54gene do?
54gene is a biotechnology company.
Where is 54gene headquartered?
54gene is headquartered in San Francisco, US.
Which VCs invest in companies like 54gene?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at 54gene's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like 54gene? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.